IXC 2.78% 7.0¢ invex therapeutics ltd

Peptron is a pharmaceutical company in south korea. They are...

  1. 795 Posts.
    lightbulb Created with Sketch. 45
    Peptron is a pharmaceutical company in south korea. They are developing exenatide (pt320, glp1 receptor agonist, presendin, exendin-4 are all other names for this) but they are developing it for use in parkinsons disease. We are developing it for iih. We have a manufacturing agreement with peptron to buy the formulation from them if we get approved. We have the patents for it in eu uk us au jp in iih, they have exclusive rights for it in sk in iih as well that we gave them, as well as worldwide in parkinsons. Thats the dumbed down version
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
-0.002(2.78%)
Mkt cap ! $5.261M
Open High Low Value Volume
7.0¢ 7.3¢ 7.0¢ $3.658K 50.82K

Buyers (Bids)

No. Vol. Price($)
1 91099 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 37500 1
View Market Depth
Last trade - 15.07pm 26/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.